bullish
Classys (214150 KS): 2023 Sales Beat Guidance to Reach Record High; Stellar Performance to Continue
341 Views01 Mar 2024 09:30
SUMMARY
- Classys (214150 KS) achieved its highest performance ever in 2023. Revenue grew 27% YoY to KRW180 billion, 6% higher than the forecast of KRW170 billion announced early last year.
- As demand for equipment increased rapidly in major countries, overseas sales last year exceeded KRW100 billion for the first time, and specially in Brazil, annual sales exceeded KRW40 billion.
- With a positive outlook, Classys is expected to maintain growth trajectory. The company expects 2024 annual revenue of KRW225 billion, up 25% YoY.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Merger Between Classys and Ilooda Likely to Reduce Local Competition26 Jun 2024
- Classys (214150 KS): Beautiful Journey Continues; Record High Revenue and Operating Profit in 1Q2409 May 2024
- Classys: One of Korea's Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends08 Mar 2024
- Classys (214150 KS): Record High Quarterly Performance in Q3; 2024 to Continue to Be Radiant26 Nov 2023
- Classys (214150 KS): Beautiful Growth Story Continues; No Sign of Slowing Down11 Sep 2023
- Classys (214150 KS): Strong 1Q23 Result Lifted by Overseas Performance and Consumables Sales26 May 2023
x